Comparison

Evoxa vs Sarpkaya

Price, ratings, monetisation and update history for both apps, side by side β€” with what reviewers say about each.

Head to head
About

Evoxa

Features
Read full description

Evoxa helps you explore England respiratory health statistics from the UK Health Security Agency (UKHSA) on iPhone. It uses the official public API to deliver charts, a personal watchlist, and export tools built for mobile. KEY FEATURES - Dashboard: star and reorder favorite metrics; open full charts in one tap - Insights: all indicators at a glance; sort and filter week-over-week movers - Compare: overlay two metrics; drag for dual readouts on an indexed chart - Explorer: add UKHSA respiratory indicators beyond the 12 presets - Widget and local alerts for pinned or starred metrics - CSV export, PNG sharing, and on-device cache with stale-data banner METRICS Line charts with search, sex/age filters, and time ranges (4W, 12W, 1Y, All). Drag to inspect points. Twelve built-in indicators cover influenza, RSV, NHS 111 calls, COVID PCR, and related series. INSIGHTS AND DASHBOARD Snapshot cards with trend direction and week-over-week notes. Tap through to Metrics. Favorites support 7d, 28d, and 1y change windows.

About

Sarpkaya

Features
Read full description

Sarpkaya is a clean market companion for iPhone. The Dashboard summarizes market overview, your watchlist, and quick symbol search. Markets helps you browse US stocks and ETFs, filter by category, and manage favorites. Each quote page shows price, change, and day range, with optional price alerts via local notifications. Quotes can be cached on your device for offline reference. A Home Screen widget highlights a symbol from your watchlist and opens the app in one tap. Settings stay simple: notifications and refresh. No account required. No ads. Market information is for reference onlyβ€”not investment advice.

Screenshots

Evoxa4 screens
Sarpkaya4 screens

Verdict

The call

Evoxa and Sarpkaya are too close to call on the numbers: across 5 compared parameters β€” price, ads, in-app purchases and device support among them β€” neither pulls far enough ahead to decide it. What separates them is feature set and interface, not measurable difference.

Scored on Price Β· Rating Β· Positive reviews Β· Number of ratings Β· Update frequency Β· Ads Β· In-app purchases Β· Monetization Β· Best chart rank Β· Devices Β· Requires iOS

CostPrice Β· In-app purchases Β· Ads Β· Monetization

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

ScorecardNo meaningful differences
Evoxa versus Sarpkaya: the parameters behind the verdict, then further details
ParameterEvoxaSarpkaya
PriceFreeFree
Update frequencyβ€”Every 9 days
AdsNoNo
In-app purchasesNoNo
DevicesiPhoneiPhone
Requires iOS16.016.0
Further details β€” not scored
Size4 MB1 MB
Age rating17+17+
DeveloperARSLAN SERAFETTINAKDENIZ MUSTAFA

In-app purchases

None

Evoxa

No in-app purchases

None

Sarpkaya

No in-app purchases

Questions

Is Evoxa free?
Evoxa is free to download, with no in-app purchases.
Is Sarpkaya free?
Sarpkaya is free to download, with no in-app purchases.
Do Evoxa or Sarpkaya have ads?
Neither Evoxa nor Sarpkaya shows ads.

Other comparisons